162 related articles for article (PubMed ID: 36961080)
1. LncRNA FOXP4-AS1 silencing inhibits metastasis and epithelial-mesenchymal transition in nasopharyngeal carcinoma via miR-136-5p/MAPK1.
Yan J; Zhou Q
Anticancer Drugs; 2023 Nov; 34(10):1104-1111. PubMed ID: 36961080
[TBL] [Abstract][Full Text] [Related]
2. LncRNA FOXD3-AS1/miR-135a-5p function in nasopharyngeal carcinoma cells.
E Z; Li C; Xiang Y
Open Med (Wars); 2020; 15(1):1193-1201. PubMed ID: 33336076
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.
Zheng YJ; Zhao JY; Liang TS; Wang P; Wang J; Yang DK; Liu ZS
FASEB J; 2019 Nov; 33(11):12915-12928. PubMed ID: 31557058
[TBL] [Abstract][Full Text] [Related]
4. LncRNA BBOX1-AS1 Contributes to the Development of Nasopharyngeal Carcinoma via miR-204-5p/MUC4 Axis.
Xiong J; Zhou L; Zhou Y
Ann Clin Lab Sci; 2023 May; 53(3):366-379. PubMed ID: 37437933
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TP73-AS1 regulates miR-495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A.
Dai BQ; Jiang X; Feng LC
Kaohsiung J Med Sci; 2021 May; 37(5):361-370. PubMed ID: 33400379
[TBL] [Abstract][Full Text] [Related]
6. lncRNA MSC-AS1/miRNA-429 Axis Mediates Growth and Metastasis of Nasopharyngeal Carcinoma via JAK1/STAT3 Signaling Pathway.
Luo N
Comput Math Methods Med; 2022; 2022():1447207. PubMed ID: 36213586
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG1 promotes nasopharyngeal carcinoma development via targeting miR-424-5p.
Zhou Z; Chen Y
Histol Histopathol; 2023 Aug; 38(8):953-963. PubMed ID: 36727428
[TBL] [Abstract][Full Text] [Related]
8. Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis.
Cheng Z; Jiang S; Tao R; Ge H; Qin J
Bioengineered; 2022 Feb; 13(2):2114-2129. PubMed ID: 35034547
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma.
Zhong LK; Zhou J; He X; He BF; Zhou XW; Zhu JL; Liu J; Qiu YH
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8008-8016. PubMed ID: 32767327
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA C5orf66-AS1 inhibits osteosarcoma cell proliferation and invasion via miR-149-5p upregulation.
Zhang H; Song J
Oncol Lett; 2021 Nov; 22(5):757. PubMed ID: 34539861
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FOXP4-AS1 Is Involved in Cervical Cancer Progression via Regulating miR-136-5p/CBX4 Axis.
Zhao J; Yang T; Li L
Onco Targets Ther; 2020; 13():2347-2355. PubMed ID: 32256085
[TBL] [Abstract][Full Text] [Related]
14. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
15. LncRNA CDKN2B-AS1 Promotes Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma via Sponging miR-424-5p.
Shen X; Li Y; He F; Kong J
Cancer Manag Res; 2020; 12():6807-6819. PubMed ID: 32801906
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
[TBL] [Abstract][Full Text] [Related]
17. CDKN2B-AS1 promotes the proliferation, clone formation, and invasion of nasopharyngeal carcinoma cells by regulating miR-98-5p/E2F2 axis.
Li Z; Cai X; Zou W; Zhang J
Am J Transl Res; 2021; 13(12):13406-13422. PubMed ID: 35035684
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2).
Yao H; Yang L; Tian L; Guo Y; Li Y
Cancer Cell Int; 2020; 20():138. PubMed ID: 32368184
[TBL] [Abstract][Full Text] [Related]
19. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
[TBL] [Abstract][Full Text] [Related]
20. LncRNA IGBP1-AS1 targets miR-150-5p to increase ZEB1 expression in nasopharyngeal carcinoma.
Wang LJ; Wang YS; Zhao Y
Transl Cancer Res; 2022 Mar; 11(3):530-537. PubMed ID: 35402187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
